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Foreword
We are pleased to write an introduction to this second issue of
Volume 12 of the Annals, an issue of which we are particularly
proud for at least two reasons. First, with this issue the Annals
officially moves to a bi-annual journal, a long contemplated
move that we believe is responsive to the sophistication of the
health law field, and the rapidity with which new developments
occur. By now publishing twice yearly we intend the Annals to
be more responsive to academic and practitioner needs for a
source which critically analyzes some of the most important issues arising in health law.
This issue is also important because it contains papers from
the Institute for Health Law's annual Health Law and Policy
Colloquium. The Colloquium, now beginning its third year, is
an invitation only event designed to attract thought-leaders
gathering to dialogue about a health policy issue of national import. The 2002 Colloquium attracted more than one hundred
academics, general counsels from health care providers and payers, government officials, consultants, executives, physician
leaders, and senior law firm partners to discuss the role of the
hospital medical staff and board of directors in assuring high
quality medical care. The conversation was energizing, with significant debate occurring in the room regarding the role and responsibility of the board and the medical staff, and where the
province of each begins and ends.
The first four papers of this Volume capture much of the debate occurring during the Colloquium. In "The Hospital Board
at Risk and the Need to Restructure the Relationship with the
Medical Staff: Bylaws, Peer Review and Related Solutions,"
John Marren and Michael Paddock from Hogan Marren, and
Landon Feazell from QualVal Health Systems, Inc., set forth the
parameters of the Colloquium debate, arguing that the current
quality assurance structure, whereby the hospital board delegates quality assurance to the medical staff-while ultimately
remaining legally responsibility for its performance-is unworkable. Reviewing the role of Board and medical staff quality
activities in the contemporary hospital, the authors argue that
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the traditional independence
medical staff from the hospital enables medical staffs, potentially, to poorly perform their
delegated responsibilities. This then leaves hospital boards,
which are typically unskilled in quality matters, with little effective recourse short of drastic measures. The authors challenge
the statutory, regulatory, and accreditation schema which establish this framework, and propose changes to address these
shortcomings.

Mr. Ronald Spaeth, a senior executive with Evanston Northwestern Healthcare, provided a chief executive officer perspective to the proceedings. He focuses on the administrationphysician linkage, and how this relationship must be developed
to effectuate high quality medical care. In his article, "Quality
Assurance and Hospital Structure: How the Physician-Hospital
Relationship Affects Quality Measures," Mr. Spaeth examines
quality in the academic and community hospital settings, and reviews the differences in each due to organizational structure of
the quality function. In doing so, he argues that the challenges
of community hospitals, which in most cases rely upon the good
graces of physicians in order to generate referrals to the institution, provide a unique set of dynamics when it comes to enforcing quality of care standards.
In concert with Mr. Spaeth, Dr. Gerald Eisenberg, Medical
Staff President at Lutheran General Hospital provides a "real
world" perspective on quality initiatives. In "The Medical Staff
Structure-Its Role in the 21st Century," Dr. Eisenberg focuses
on the role of the independent medical staff, its organization
and internal workings, and the role that it must play to assure
high quality medical care. He provides insights into some of the
most prevalent conflicts between hospitals and their physicians,
and offers suggestions to ameliorate some of the most significant
conflicts between the two.
In our last Colloquium paper Elizabeth Snelson, a medical
staff attorney, offers her perspective as an advocate of physician
rights in the institutional quality mechanism. She supports the
legal framework underlying the medical staff role in quality activities, and reviews case law concerning medical staff bylaws'
protection of physicians' legitimate role in quality activities. Bylaw provisions, which in her view denigrate the physicians' roles
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and responsibilities, are discussed with sample language for protective medical staff bylaw provisions posited.
In short, I believe you will find these four papers from the
annual Colloquium, which offer insights from four unique perspectives-hospital attorney, executive, medical staff leader,
and medical staff attorney-enlightening, and that you will enjoy joining this debate as much as we did.
This issue of the Annals also continues the Journal's tradition
of publishing intriguing articles anticipating significant developments in the field of health law. Professor Ross Silverman, in
"No More Kidding Around: Restructuring Non-Medical Childhood Immunization Exemptions to Ensure Public Health Protection" enters a particularly significant debate occurring within
the health care and health law communities, analyzing childhood immunization programs. The issue has particular relevance given the controversy surrounding the possible rollout of
a mass smallpox vaccine program. Prof. Silverman begins his
paper by reviewing the history of immunization programs and
the inconsistency of state enforcement of immunization laws and
exemptions, using situations arising in New York, Wyoming, and
Arkansas to illustrate his points. In doing so, Prof. Silverman
demonstrates significant weaknesses in our public health systems. He also raises questions about the conflict between public
health and individual autonomy. Prof. Silverman concludes by
advocating an informed refusal approach as a way to protect autonomy, while assuring that public health programs have the
maximum impact possible to protect public welfare and safety.
Professor James O'Reilly and Nancy Hui have authored articles focusing on the pharmaceutical industry, an area of particular import given the current policy discussion on prescription
drug coverage. In his article titled "Off-Label or Out of
Bounds?: Prescriber and Marketer Liability for Unapproved
Uses of FDA-Approved Drugs," Prof. O'Reilly studies promotion practices for unapproved uses of prescription drugs, an issue with significant quality and cost implications. He criticizes
Congress for moving away from what he believes was a patient
protective review framework and towards a more industry
friendly, albeit expansive, approach. He argues that the health
consequences of off-label drug use were not well understood by
Congress when it passed significant changes to the drug review
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in passing
these 1997 amendments Congress sacrificed the public's health while significantly expanding
pharmaceutical profits.

Ms. Hui looks at a related issue which also has significant
quality and cost ramifications, and that is the generic drug approval process. Specifically, she focuses upon a recent Food
and Drug Administration proposal modifying regulations regarding generics, which regulations have been used to delay or
defeat generic drug applications. Ms. Hui discusses the contents
of the proposed regulations, and analyzes their likely impact on
patients and the pharmaceutical industry.
In her article "The Bipartisan Patient Protection Act: Greater
Liability on Managed Care Plans," Urura Mayers examines a
topic which has been percolating for some time in Congress, patient protection legislation. Specifically, she examines competing House and Senate versions of this legislation, critically
examining the protections offered in each. In the course of her
analysis Ms. Mayers proposes various amendments to the Employee Retirement Income Security Act ("ERISA"), since the
law has a significant impact on the management of health care
plans. Ms. Mayers also raises the troubling issue of access to
care for those lacking insurance, and the failure of patient protection legislation to address this significant problem.
Finally, Ms. Zabawa picks up on Ms. Mayers challenge, examining access to care in the context of federally funded health
care programs, focusing specifically upon the Medicaid waiver
process. The paper has special resonance given the Administration's desire to offer more flexibility, with significantly more financial risk, to the states. Ms. Zabawa reviews the history of
waivers and the projects it has spawned, and the role of a collaborative, community-oriented approach to health care delivery.
She posits that a collaborative process, involving a true partnership between government and the community it desires to
serves, holds the best promise for chipping away at the health
care access problem.

With this issue we say farewell to many of the fine editors who
served on the Annals staff this year. They have done a fantastic
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job, and positioned the Annals well for a bright future. While
the contributions of all are significant, we give a special thanks
to Jeffrey Kee, the Annals' Editor-in-Chief, for his leadership in
converting the Annals to a bi-annual journal, and for providing
a framework under which the Annals is surely to grow and
prosper.
Finally, with this issue of the Annals, we complete the design
makeover intended to visually demonstrate the new direction
set for the Annals. We hope you are as pleased by it as we are.
Let us conclude by stating that the Annals represents the best
of what the Institute for Health law stands for: a center for serious dialogue and advancement of the field of health law. We
are proud to be a leader in this dynamic field, and encourage
you to contact us if you would like to become involved in our
myriad endeavors.
Larry Singer
Director
Institute for Health Law
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